Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA And Generic Drug Quality: Turning Point, Or Precipice?

Executive Summary

OGD Director Geba says generic manufacturers still suffer from extensive quality problems, but GPhA officials argue the industry is doing fine and communications with the agency need to be more uniform.

Advertisement

Related Content

Drug GMP “Surveillance” Will Link Compliance Information To Inspections
FDA GMP “Surveillance” Will Link Quality, Compliance Information To Inspections
Generic Bupropion XL Must Be Retested; Teva/Impax 300 mg Withdrawn After Efficacy Concerns
Drug Shortages Mostly FDA’s Fault, House Oversight Committee Concludes
PDUFA’s ‘Huge’ GMP Change Will Tie Adulteration To Quality System
Generic Drug Shortages Threaten Industry’s Reputation, Hamburg Cautions
GOP Drug Shortage Strategy Pushes FDA Reform, Reimbursement Over Notification
Generic User Fee Agreement Includes FDA Pledge To Determine Best Use Of Foreign Regulator Inspections
To Prevent Drug Shortages, Don't Look To Inspections, FDA Says
FDA's Woodcock Expresses Concern Not All Generics Are Equivalent, But OGD May Have Solution

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS054786

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel